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Abstract 
The BioMerieux NucliSENS easyMAG total nucleic acid extractor was evaluated for use on bacterial isolates in the 
clinical microbiology laboratory. Forty eight isolates were extracted, yielding quantifiable amounts of DNA for all 
isolates. The easyMAG is appropriate for DNA extraction from bacterial isolates and will be incorporated in the clinical 
laboratory.
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The number of molecular methods and their importance 
in the clinical microbiology laboratory is rapidly increas-
ing. Nucleic acid extraction from bacterial isolates is an 
important first step in several molecular test methodolo-
gies, including 16S rRNA sequencing for bacterial iden-
tification, whole genome sequencing, and other geno-
typic methods. While some clinical microbiology testing 
platforms have integrated nucleic acid extraction, others 
require separate nucleic acid extraction before testing 
may begin. Laboratory quality control has recently come 
under renewed scrutiny with the implementation of indi-
vidual quality control plan (IQCP) requirements and as 
part of this, it is critically important to identify steps in a 
testing process that may result in testing failure or testing 
delays.
Inadequate nucleic acid extraction may result in an 
insufficient amount of nucleic acids, which can result in 
wasted reagents and delayed results. Manual extraction 
methods have traditionally been used, but these meth-
ods require extensive hands-on time and frequently have 
many steps, which increases the opportunity for method 
error or sample contamination [1]. The NucliSENS 
easyMAG total nucleic acid extractor (bioMérieux, 
Marcy l’Etoile, France) is a platform capable of total 
nucleic acid extraction from various sources, including 
blood, stool, and urine. The easyMAG extracts nucleic 
acids using magnetic silica beads. EasyMAG extraction 
of clinical samples such as respiratory samples, stool, 
and blood followed by molecular detection of viral and 
bacterial pathogens has been reported [2–4]. While the 
easyMAG has been used on a variety of clinical speci-
men types, the extractor does not include pre-set pro-
tocols for bacterial extraction. Although a small number 
of published studies have utilized the easyMag extrac-
tor to extract nucleic acids from bacterial isolates, these 
have typically been limited to a small range of species [5]. 
For the easyMAg to be utilized as the primary bacterial 
nucleic acid method in a clinical microbiology laboratory, 
the extractor must be capable of extracting nucleic acids 
from a wide variety of bacterial species. To determine the 
suitability of the easyMAG for routine bacterial nucleic 
acid extraction, the current study sought to examine the 
ability of the easyMag extractor to extract nucleic acids 
from a wide variety of bacterial isolates.
Forty-eight isolates from the American Type Cul-
ture Collection (ATCC) were selected to represent the 
wide variety of isolates typically encountered in a clini-
cal microbiology laboratory (Table  1). Organisms were 
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assigned to one of four groups: Gram-positive cocci, 
Gram-positive bacilli, Gram-negative bacilli in the family 
Enterobacteriaceae, and Gram-negative bacilli other than 
Enterobacteriaceae. A 1.0 McFarland suspension of each 
isolate in 0.45  % saline was made using the bioMérieux 
DensiCheck. 100 microlitre of each isolate was placed 
in the vessel portion of the easyMAG disposables and 
inserted in the instrument. DNA extraction was set up 
using the following parameters: program-specific 1.0.1, 
volume (input)-0.1 mL, elution volume-110 µL; lysis- on 
board. Ten microlitre of the resulting nucleic acid elu-
ent was quantified using the Eppendorf Biophotometer 
(Eppendorf, Hauppauge, New York, USA).
For each of the four groups, the two isolates with the 
lowest nucleic acid concentrations were submitted for 
16S rRNA sequencing. When these two isolates were 
from the same genus, the isolate with the next low-
est nucleic acid concentration was submitted, ensuring 
more diverse representation of each group. Sequencing 
results were compared to the ATCC identification of the 
organism to ensure correct identification. Four additional 
isolates yielding higher extracted DNA concentrations 
(7.8–21.6 ng/µL) were also sequenced.
Extraction with the easyMAG resulted in detectable 
amounts of nucleic acids for all isolates (Table 2). Gram-
positive organisms generally resulted in lower nucleic 
acid concentrations and A260/A280 ratios than Gram-
negative organisms. A260/A280 is a measure of nucleic acid 
purity [6]. A260/A280 of 1.8 represents pure DNA, while an 
A260/A280 of 2.0 represents pure RNA. Lower values are 
typically the result of protein contamination. For those 
isolates with the lowest concentrations of nucleic acids 
in each group, 16S rRNA sequencing was successful. It is 
expected that isolates yielding higher concentrations of 
DNA would also sequence, as low DNA quantity is fre-
quently cited as the reason isolates cannot be sequenced. 
To confirm this, four isolates with higher extracted DNA 
concentrations were also sequenced, and all yielded iden-
tifications. Low A260/A280 also did not affect downstream 
16S rRNA testing, as isolates with A260/A280 as low as 
1.05 were sequenced successfully. Low ratios are likely 
the result of protein in the DNA extract, which does not 
prevent downstream testing. It is expected that nucleic 
acids from easyMAG extractions will be suitable for 
other PCR-based methodologies.
In-house nucleic acid extraction can decrease turn-
around-time of downstream testing and minimizes 
the risks associated with sending potential pathogens 
to other laboratories. Coupling laboratory-performed 
nucleic acid extraction with nucleic acid quantification 
allows laboratories to perform additional manipulation 
on isolates that initially do not yield adequate amounts 
of nucleic acid. Identification of these isolates before 
downstream testing can prevent unsuccessful testing, 
save reagents and testing time, and decrease overall time 
Table 1 Bacterial species included in validation
Gram-positive cocci Gram-positive bacilli Enterobacteriaceae Non-Enterobacteriaceae gram-negative organisms
Staphylococcus epidermidis Streptomyces albus Escherichia coli (3) Campylobacter jejuni
Staphylococcus aureus Exiguobacterium mexicanum Providencia stuartii Campylobacter coli
Enterococcus faecium Clostridium septicum Salmonella enterica Pseudomonas aeruginosa (2)
Streptococcus pyogenes Actinomyces viscosus Shigella sonnei Prevotella melaninogenica
Staphylococcus saprophyticus Propionibacterium acnes Plesiomonas shigelloides Stenotrophomonas maltophilia
Enterococcus faecalis Corynebacterium striatum Enterobacter cloacae Alcaligenes faecalis
Streptococcus pneumoniae Clostridium perfringens Vibrio vulnificus Acinetobacter baumannii
Streptococcus mitis Actinomyces pyogenes Klebsiella oxytoca Haemophilus influenzae
Streptococcus agalactiae Streptomyces griseus Citrobacter freundii Burkholderia cepacia
Listeria monocytogenes Proteus mirabilis (2) Neisserisa meningitidis
Klebsiella pneumoniae Pseudomonas putrefaciens
Serratia marcescens Pasteurella multocida
Bordetella bronchiseptica
Moraxella catarrhalis





Median Range Median Range
Gram-positive cocci 8.5 7.4–14.5 1.35 1.05–1.70
Gram-positive bacilli 9.1 8.0–37.8 1.47 1.09–1.80
Enterobacteriaceae 15.9 12.1–20.4 1.63 1.27–1.94
Non-Enterobacteriaceae 17.4 7.8–22.0 1.67 1.02–1.82
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to test result. While this was not required in the current 
study, lysis can be performed manually rather than on the 
instrument to extend lysis time and additional physical 
lysis steps such as grinding can also be added. Additional 
studies are necessary to develop protocols for nucleic acid 
extraction from acid-fast bacilli and fungi. The efficacy, 
flexibility, and ease-of-use of the bioMérieux NucliSENS 
easyMAG total nucleic acid extractor make it suitable for 
use in the routine clinical microbiology laboratory.
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